New pill aims to calm the fire in COPD lungs
NCT ID NCT07329946
Summary
This study is testing if adding a pill called erdosteine to standard COPD inhaler therapy can help control the disease by reducing harmful inflammation and oxidative stress in the lungs. It will involve 30 adults with moderate to severe COPD who are already on stable inhaler treatment. Researchers will compare those taking the pill plus their inhalers to those using inhalers alone for four weeks, looking at blood markers and symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COPD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
L. Sacco Hospital
Milan, 20157, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.